ZS Pharma, Inc. (ZSPH) was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company, as the stock has lost over 8% since Aug 26.
This development stage biopharmaceutical company has seen no estimate revisions in the last 30 days. The Zacks Consensus Estimate has also remained unchanged over the same time frame. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
ZS Pharma currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Investors looking for well-positioned stocks in the pharmaceutical sector may consider Endo International plc (ENDP), Lannett Company, Inc. (LCI) and Hyperion Therapeutics, Inc. (HPTX). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment